Intraoperative CO₂ (Carbon Dioxide)
ConditionWound Edges
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-89
SponsorBaylor Research Institute
About this trial
To evaluate whether intraoperative fractionated CO₂ laser treatment of surgical wound edges improves postoperative scar appearance compared with untreated wound edges following Mohs micrographic surgery (MMS).
Eligibility criteria
Qualifiers
Adults aged 18-89 years
Diagnosis of cutaneous malignancy treated with MMS
Surgical defect suitable for primary linear or flap closure with adequate length to permit split-scar design
Ability to understand and provide informed consent
Disqualifiers
Pregnancy
Inability to provide informed consent
Non-English speaking patients
History of abnormal wound healing (e.g., keloid disorder)
Trial design
Treatments tested in this trial
- CO2 Fractionated Laser
- Non CO2 Laser Treatment
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov